n-acetylneuraminic acid has been researched along with Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, M; Brandis, A; Cahalon, L; Clark, AR; Colaiuta, SP; Croese, T; Gold, O; Greka, A; Habib, N; Itkin, M; Kitsberg, D; Kohnert, E; Malitsky, S; Medina, S; Mehlman, T; Ravid, A; Salame, TM; Schwartz, M; Shapira, I; Slyper, M; Suzzi, S; Vernon, KA | 1 |
| García Rodríguez, JC; Maurice, T; Rodríguez Cruz, Y; Rodríguez Obaya, T; Strehaiano, M | 1 |
2 other study(ies) available for n-acetylneuraminic acid and Memory Disorders
| Article | Year |
|---|---|
N-acetylneuraminic acid links immune exhaustion and accelerated memory deficit in diet-induced obese Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Animals; Diet, High-Fat; Disease Models, Animal; Humans; Memory Disorders; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Obesity | 2023 |
An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Disease Models, Animal; Erythropoietin; Hippocampus; Maze Learning; Memory; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; N-Acetylneuraminic Acid; Neuroprotective Agents; Nootropic Agents | 2017 |